ADAR1 Capital Management LLC Buys New Stake in Septerna, Inc. $SEPN

Key Points

• ADAR1 Capital Management acquired 940,747 Septerna shares worth approximately $31.5 million, giving it about 2.02% of the company and making Septerna its 11th-largest portfolio holding.
• Analysts remain broadly bullish, with a “Moderate Buy” consensus and an average price target of $52.44; several firms recently raised their targets to between $48 and $62.
• Septerna’s latest quarterly results exceeded expectations, with an adjusted loss of $0.29 per share versus the $0.43 consensus estimate and revenue of $26.75 million against forecasts of $19.22 million.

ADAR1 Capital Management LLC purchased a new stake in Septerna, Inc. (NASDAQ:SEPN - Free Report) during the second quarter, according to its most recent filing with the SEC. The fund purchased 940,747 shares of the company's stock, valued at approximately $31,506,000. Septerna comprises about 1.4% of ADAR1 Capital Management LLC's portfolio, making the stock its 11th largest holding. ADAR1 Capital Management LLC owned approximately 2.02% of Septerna as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of SEPN. Renaissance Technologies LLC bought a new stake in Septerna in the 1st quarter worth approximately $906,000. TRV GP VI LLC bought a new position in shares of Septerna during the 2nd quarter valued at approximately $141,048,460,000. First Light Asset Management LLC boosted its position in shares of Septerna by 18.0% during the 1st quarter. First Light Asset Management LLC now owns 732,860 shares of the company's stock valued at $17,611,000 after acquiring an additional 112,049 shares during the last quarter. Janus Henderson Group PLC purchased a new position in shares of Septerna in the first quarter valued at $21,334,000. Finally, TRV GP V LLC purchased a new position in shares of Septerna in the second quarter valued at $208,160,143,000.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on SEPN shares. JPMorgan Chase & Co. upped their price target on shares of Septerna from $38.00 to $48.00 and gave the company an "overweight" rating in a research note on Wednesday, August 19th. JonesTrading lifted their price objective on shares of Septerna from $43.00 to $62.00 and gave the stock a "buy" rating in a research note on Thursday, August 13th. Guggenheim boosted their target price on shares of Septerna from $45.00 to $51.00 and gave the stock a "buy" rating in a report on Tuesday, August 11th. HC Wainwright upped their target price on shares of Septerna from $40.00 to $60.00 and gave the company a "buy" rating in a research report on Wednesday, August 12th. Finally, Raymond James Financial reaffirmed a "strong-buy" rating and issued a $49.00 price target on shares of Septerna in a report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $52.44.

Insider Transactions at Septerna

In related news, insider Samira Shaikhly sold 2,178 shares of the business's stock in a transaction on Monday, June 29th. The stock was sold at an average price of $35.18, for a total transaction of $76,622.04. Following the completion of the transaction, the insider owned 793 shares in the company, valued at $27,897.74. The trade was a 73.31% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Daniel D. Long sold 3,334 shares of the company's stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $34.47, for a total value of $114,922.98. Following the completion of the transaction, the senior vice president directly owned 96,412 shares in the company, valued at $3,323,321.64. This trade represents a 3.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 61,030 shares of company stock worth $2,329,666. 5.80% of the stock is currently owned by company insiders.

Septerna Stock Up 1.9%

NASDAQ SEPN opened at $41.30 on Wednesday. Septerna, Inc. has a 52 week low of $11.70 and a 52 week high of $51.10. The firm has a market capitalization of $1.93 billion, a price-to-earnings ratio of -76.48 and a beta of 2.29. The company has a fifty day moving average of $37.06 and a two-hundred day moving average of $30.54.

Septerna (NASDAQ:SEPN - Get Free Report) last released its earnings results on Monday, August 10th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.14. Septerna had a negative net margin of 24.51% and a negative return on equity of 9.57%. The firm had revenue of $26.75 million during the quarter, compared to analyst estimates of $19.22 million. Equities research analysts anticipate that Septerna, Inc. will post -1.41 EPS for the current year.

Septerna Company Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. GPCRs are the largest and most diverse family of cell membrane receptors and regulate physiological processes in nearly every organ system of the human body.

Want to see what other hedge funds are holding SEPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Septerna, Inc. (NASDAQ:SEPN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source